Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883513 · ClinicalTrials.gov registry record · NA

Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID

A NA study of Long COVID and PASC, sponsored by University of Louisville.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06883513: Recruiting NA study of Long COVID and PASC, sponsored by University of Louisville.

NCT06883513 is a NA study of Long COVID and PASC that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 20 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883513, a NA study of Long COVID and PASC, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in individuals suffering from Long-COVID olfactory (smell) dysfunction in a small single-blinded pilot trial conducted during 2021. The questions this study is trying to answer are: 1. Does this OMT protocol improve other non-smell related Long-COVID symptoms 2. Do 2 OMT treatments improve Long-COVID symptoms more than 1 OMT treatment Participants will: 1. Week 1: Take an digital survey regarding their Long-COVID symptoms undergo Long-COVID OMT treatment or a placebo treatment 2. Week 2: Take an digital survey regarding their Long-COVID symptoms then all will undergo Long-COVID OMT treatment 3. Week 3: Take an digital survey regarding their Long-COVID symptoms 4. Week 8: Take an digital survey regarding their Long-COVID symptoms

Primary Outcome

The Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC) is a validated tool generated to assess for Long-COVID symptom burden generated by the University of Birmingham in the UK. The SBQ™-LC assesses 123 different symptoms of Long COVID. All items use the recall period "In the last 7 days..." and are scored according to one of the following: 1. symptom presence (Yes/No); 2. symptom frequency (0 = Never to 3 = Always); 3. symptom severity (0 = None to 3 = Severe); 4. or Interference in daily

Interventions

  • OTHER Osteopathic Manipulative Therapy Long-COVID protocol
  • OTHER Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol

Study Locations (1)

Kentucky

  • University of Louisville Outpatient Care Center - Louisville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-01
Est. Completion 2025-07-03
Phase NA
University of Louisville

217 total trials

What NCT06883513 shows while recruiting

NCT06883513 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Long COVID appearing as the primary indexed condition, and to 2 interventions - of which Osteopathic Manipulative Therapy Long-COVID protocol is the first listed.

NCT06883513 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT06883513 about?

NCT06883513 is a clinical study titled "Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID". This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in individuals suffering from Long-COVID olfactory (smell) dysfunction in a small single-blinded pilot trial conducted during 2021. The questio...

What is the current status of trial NCT06883513?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-01. Estimated completion is 2025-07-03.

What conditions does trial NCT06883513 study?

This clinical trial studies the following conditions: Long COVID, PASC, Long COVID Syndrome.

What interventions are being tested in trial NCT06883513?

The interventions under investigation include: Osteopathic Manipulative Therapy Long-COVID protocol (OTHER), Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol (OTHER).

Who is sponsoring clinical trial NCT06883513?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06883513 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06883513's enrollment target sits among peer trials

20 47th of 50 higher than 3 of 50 other Long COVID trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06883513, the US trial registry maintained by the National Library of Medicine. NCT06883513 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.